http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/ Y! Health Arthritis News, updated continuously. en-us Sun, 06 Jul 2008 18:22:00 PDT Copyright (c) 2008 Yahoo! Inc. All rights reserved. 5 142 18 http://health.yahoo.com/ http://us.i1.yimg.com/us.yimg.com/i/us/he/b/he_144.gif http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/highbirthweightdoublesriskofrheumatoidarthritis.htmlyahoo/health/news/healthday/highbirthweightdoublesriskofrheumatoidarthritisMon, 30 Jun 2008 20:46:21 PDTHealthDay - MONDAY, June 30 (HealthDay News) -- The risk of rheumatoid arthritis is twice as high in women who had a heavy birth weight (more than 10 pounds) than those with an average birth weight (7 to 8.5 lbs), a new study finds.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/heavy_babies_dc.htmlyahoo/health/news/reuters/heavy_babies_dcMon, 30 Jun 2008 10:15:37 PDTReuters - People who were heavier than average when they were born appear to be twice as likely to develop rheumatoid arthritis as their normal birth-weight counterparts, researchers report.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/hipreplacementboostsmobilityatanyage.htmlyahoo/health/news/healthday/hipreplacementboostsmobilityatanyageFri, 27 Jun 2008 20:47:03 PDTHealthDay - FRIDAY, June 27 (HealthDay News) -- Total hip replacements are beneficial and economical for seniors with osteoarthritis, regardless of their age, say researchers at Duke University Medical Center.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/rheumatoidarthritistreatmentguidelinesupdated.htmlyahoo/health/news/healthday/rheumatoidarthritistreatmentguidelinesupdatedThu, 26 Jun 2008 20:47:44 PDTHealthDay - THURSDAY, June 26 (HealthDay News) -- New recommendations for the use of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis (RA) have been developed by the American College of Rheumatology.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/rheumatoidarthritisdrugboostsmelanomaincidence.htmlyahoo/health/news/healthday/rheumatoidarthritisdrugboostsmelanomaincidenceFri, 20 Jun 2008 20:47:43 PDTHealthDay - FRIDAY, June 20 (HealthDay News) -- Rheumatoid arthritis (RA) patients treated with methotrexate have an increased incidence of melanoma and other cancers, an Australian study says.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/fdapanelrecommendsenbrelforpediatricpatients.htmlyahoo/health/news/healthday/fdapanelrecommendsenbrelforpediatricpatientsWed, 18 Jun 2008 20:46:57 PDTHealthDay - WEDNESDAY, June 18 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel recommended Wednesday that the psoriasis drug Enbrel be approved for use in children who have moderate-to-severe forms of the skin disease.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/arthritis_heart_dc.htmlyahoo/health/news/reuters/arthritis_heart_dcFri, 13 Jun 2008 03:37:35 PDTReuters - People with rheumatoid arthritis have double the risk of suffering heart attacks or strokes and should be considered for treatment with statins and blood pressure drugs, rheumatology experts said on Friday.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/cimzia_dc.htmlyahoo/health/news/reuters/cimzia_dcThu, 12 Jun 2008 11:23:37 PDTReuters - Cimzia stops structural damage to joints in patients with rheumatoid arthritis as soon as 16 weeks after the start of treatment, according to new data presented on Thursday.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/golimumabeasesrheumatoidarthritissymptoms.htmlyahoo/health/news/healthday/golimumabeasesrheumatoidarthritissymptomsWed, 11 Jun 2008 20:46:45 PDTHealthDay - WEDNESDAY, June 11 (HealthDay News) -- Adding monthly injections of golimumab to weekly doses of methotrexate helped most people with rheumatoid arthritis, even putting some into remission, two new studies show.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/johnsonandjohnson_arthritis_dc.htmlyahoo/health/news/reuters/johnsonandjohnson_arthritis_dcTue, 10 Jun 2008 15:08:39 PDTReuters - An experimental treatment for rheumatoid arthritis being developed by Johnson & Johnson and Schering-Plough Corp appeared to be effective and very safe in three late-stage trials, the companies said on Tuesday.